Hala Borno, MD
Associate Professor
Medicine
School of Medicine

Dr. Borno is a medical oncologist with clinical expertise in the management of advanced urologic malignancies such as prostate, kidney, bladder, and testicular cancers. At HDFCCC, Dr. Borno serves on the executive leadership committee for the Prostate Cancer Program and the Liaison to the Office of Community Engagement. She is also a member of the American Society of Clinical Oncology Social Determinants of Health working group, and GU committee for NRG oncology. She serves as the Vice Chair of the Health Disparities Committee for Alliance for Clinical Trials in Oncology.

Dr. Borno's research program consists of prostate cancer therapeutic development and cancer disparities. She serves as medical oncology co-chair for phase III clinical trials and is the principal investigator for clinical trials conducted at HDFCCC in advanced prostate cancer. Dr. Borno has an extensive research program on the promotion of equity in cancer precision medicine.

She has developed novel recruitment technologies that are clinician and patient facing to promote diversity and inclusion of racial/ethnic minorities in clinical trials. Dr. Borno used human-centered design to develop Trial LibraryTM, a patient facing clinical trial matching tool. Dr. Borno's research has been featured in peer-reviewed journals such JAMA Oncology, Cancer, and Nature. Her work has been covered by national news outlets such as NPR, Washington Post, CBS News, Bloomberg News, and STAT News.

Dr. Borno graduated with honors in biochemistry and received her medical degree from the University of North Carolina at Chapel Hill where she was a Medical Alumni Loyalty Fund Scholar. She completed her internal medicine residency and medical oncology fellowship training at UCSF. She served as chief oncology fellow at UCSF and was a National Institute on Aging T32 research fellow in the Division of Geriatrics.

• Qualitative Study on Internet Use and Care Impact for Black Men With Prostate Cancer.
  Health education & behavior : the official publication of the Society for Public Health Education 2024 Loeb S, Sanchez Nolasco T, Byrne N, Allen L, Langford AT, Ravenell JE, Gomez SL, Washington SL, Borno HT, Griffith DM, Criner N
• Representation Matters: Trust in Digital Health Information Among Black Patients With Prostate Cancer.
  The Journal of urology 2024 Loeb S, Sanchez Nolasco T, Byrne N, Allen L, Langford AT, Ravenell J, Gomez SL, Washington SL, Borno HT, Griffith DM, Criner N
• Implementing consultation audio recording applications to improve informed decision-making (IDM) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) eligible for docetaxel.
  Journal of Clinical Oncology 2024 Daniel H Kwon, Lauren Trihy, Eliza Hearst, Nika Darvish, Gurleen Kaur, Samantha Nesheiwat, Hala Borno, Rohit Bose, Jonathan Chou, Ivan de Kouchkovsky, Arpita Desai, Kelly N. Fitzgerald, Lawrence Fong,…
• Advancing Equity in Oncology: Innovative Approaches and Robust Frameworks to Address Cancer Health Disparities.
  International Journal of Cancer Care and Delivery 2023 Michael LaPelusa, Hiba Khan, Curtiland Deville, Samuel L Washington, Hala T Borno
• Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.
  eLife 2023 Nagaraj G, Vinayak S, Khaki AR, Sun T, Kuderer NM, Aboulafia DM, Acoba JD, Awosika J, Bakouny Z, Balmaceda NB, Bao T, Bashir B, Berg S, Bilen MA, Bindal P, Blau S, Bodin BE, Borno HT, Castellano C, …
• The Effect of Racial Concordance on Patient Trust in Online Videos About Prostate Cancer: A Randomized Clinical Trial.
  JAMA network open 2023 Loeb S, Ravenell JE, Gomez SL, Borno HT, Siu K, Sanchez Nolasco T, Byrne N, Wilson G, Griffith DM, Crocker R, Sherman R, Washington SL, Langford AT
• Defining the prevalence of inherited DNA damage repair genetic variants (DDRv) in men with prostate cancer (PCa) detected by PSMA PET.
  Journal of Clinical Oncology 2023 Edward Maldonado, Thomas A. Hope, Rahul Raj Aggarwal, Daniel H Kwon, Li Zhang, Kelly Gordon, Barry Tong, Adina Bailey, Vipul Kumar, Ivan de Kouchkovsky, Vadim S Koshkin, Hala Borno, Jonathan Chou, …
• Engaging Men of Diverse Racial and Ethnic Groups With Advanced Prostate Cancer in the Design of an mHealth Diet and Exercise Intervention: Focus Group Study.
  JMIR cancer 2023 Wang EY, Borno HT, Washington Iii SL, Friedlander T, Zhang S, Trejo E, Van Blarigan EL, Chan JM, Shariff-Marco S, Beatty AL, Kenfield SA
• Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging.
  Journal of Clinical Oncology 2023 Alberto Carretero-González, Daniel Kwon, Nonna Shakhnazaryan, Julian C. Hong, Osama Mohamad, Mary Uan-Sian Feng, Ivan de Kouchkovsky, Hala Borno, Rohit Bose, Jonathan Chou, Arpita Desai, Lawrence Fong…
• Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin.
  Clinical genitourinary cancer 2023 Jindal T, Zhang L, Deshmukh P, Reyes K, Chan E, Kumar V, Zhu X, Maldonado E, Feng S, Johnson M, Angelidakis A, Kwon D, Desai A, Borno HT, Bose R, Wong A, Hong J, Carroll P, Meng M, Porten S, Aggarwal …
• The costs and inequities of precision medicine for patients with prostate cancer: A call to action.
  Urologic oncology 2023 Ragavan MV, Borno HT
• In Regard to Lastname et al.
  International Journal of Radiation Oncology • Biology • Physics 2023 Terence W. Friedlander, Hala T. Borno
• Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer.
  Frontiers in oncology 2023 Jindal T, Zhu X, Bose R, Kumar V, Maldonado E, Deshmukh P, Shipp C, Feng S, Johnson MS, Angelidakis A, Kwon D, Borno HT, de Kouchkovsky I, Desai A, Aggarwal R, Fong L, Small EJ, Wong A, Porten S, Chou…
• Nutrition Guidance for Patients on Androgen Deprivation Therapy.
  European urology focus 2023 Kenfield SA, Van Blarigan EL, Graff RE, Borno HT, Macaire G, Chan JM
• Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
  medRxiv : the preprint server for health sciences 2023 Nagaraj G, Vinayak S, Khaki AR, Sun T, Kuderer NM, Aboulafia DM, Acoba JD, Awosika J, Bakouny Z, Balmaceda NB, Bao T, Bashir B, Berg S, Bilen MA, Bindal P, Blau S, Bodin BE, Borno HT, Castellano C, …
• Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
  Journal of Clinical Oncology 2023 Kevin R Reyes, Li Zhang, Xiaolin Zhu, Tanya Jindal, Prianka Deshmukh, Ivan de Kouchkovsky, Vipul Kumar, Edward Maldonado, Daniel H Kwon, Emily Chan, Sima P. Porten, Hala Borno, Rohit Bose, Arpita …
• Association of biomarkers and response to immune checkpoint inhibitors (ICIs) in patients with metastatic urothelial carcinoma (mUC) with high and low tumor mutation burden (TMB).
  Journal of Clinical Oncology 2023 Tanya Jindal, Xiaolin Zhu, Li Zhang, Kevin R Reyes, Prianka Deshmukh, Ivan de Kouchkovsky, Vipul Kumar, Edward Maldonado, Chase Shipp, Daniel H Kwon, Hala Borno, Rohit Bose, Arpita Desai, Rahul Raj …
• Disparities in germline testing by race/ethnicity and preferred language in patients with prostate cancer.
  Journal of Clinical Oncology 2023 Annelise Thorn, Kelly Gordon, Barry Tong, Daniel H Kwon, Mallika Sachdev Dhawan, Hala Borno, Rahul Raj Aggarwal, Eric Jay Small, Amie Blanco
• Experiences of a Multiethnic Cohort of Patients Enrolled in a Financial Reimbursement Program for Cancer Clinical Trials.
  JCO oncology practice 2023 Medina SP, Zhang S, Nieves E, Dornsife DL, Johnson R, Spicer D, Borno HT
• Declining Representation and Reporting of Racial and Ethnic Minority Patients in Prostate Cancer Clinical Trials Despite Persistent Health Disparities-Where Progress Confronts Limitations.
  JAMA oncology 2023 Deville C, Borno HT
• Implementation of a Telehealth Genetic Testing Station to Deliver Germline Testing for Men With Prostate Cancer.
  JCO oncology practice 2023 Kwon DH, Gordon KM, Tong B, Borno HT, Beigh M, Fattah D, Schleicher A, Aggarwal RR, Blanco AM, Small EJ, Dhawan M
• Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention.
  Urologic oncology 2022 Langlais CS, Chen YH, Van Blarigan EL, Chan JM, Ryan CJ, Zhang L, Borno HT, Newton RU, Luke A, Bang AS, Panchal N, Tenggara I, Schultz B, Lavaki E, Pinto N, Aggarwal R, Friedlander T, Koshkin VS, …
• Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic.
  JAMA oncology 2022 Ragavan MV, Legaspi N, LaLanne A, Hong JC, Small EJ, Borno HT
• Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers.
  Urologic oncology 2022 Kwon DH, Shakhnazaryan N, Shui D, Hong JC, Mohamad O, de Kouchkovsky I, Borno HT, Bose R, Chou J, Desai A, Fong L, Friedlander TW, Koshkin VS, Aggarwal RR, Feng FY, Hope TA, Small EJ
• Impact of a Comprehensive Financial Resource on Financial Toxicity in a National, Multiethnic Sample of Adult, Adolescent/Young Adult, and Pediatric Patients With Cancer.
  JCO oncology practice 2022 Ragavan MV, Mora RV, Winder K, Incudine A, Cunningham R, Stivers T, Borno HT
• Assessing Unique Risk Factors for COVID-19 Complications Among Cancer Patients: A Multi-ethnic Cohort Study.
  Journal of immigrant and minority health 2022 Borno HT, Kim MO, Tolstykh I, Lin A, Hong JC, Yousefi S, Zhang S, McKay RR, Harismendy O, Razavi P, Cinar P, Rugo H, Koshkin VS, Rabow M, Wang C, Bailey A, Small EJ
• Reliability of real-world data for diagnosis of metastatic prostate cancer.
  Journal of Clinical Oncology 2022 Christina Phuong, Amy M. Lin, Izzy Friesner, Lisa Ni, Rahul Raj Aggarwal, Hala Borno, Vadim S Koshkin, Arpita Desai, Terence W. Friedlander, Lawrence Fong, Rohit Bose, Jonathan Chou, Tammy J. Rodvelt,…
• 1379P A phase Ib study of a single priming dose of 177Lu-PSMA-617 coupled with pembrolizumab in metastatic castration resistant prostate cancer (mCRPC).
  Annals of Oncology 2022 R. Aggarwal, L. Trihy, E. Hernandez Romero, S. Luch Sam, M. Rastogi, I. De Kouchkovsky, E.J. Small, F. Feng, D. Kwon, T. Friedlander, H.T. Borno, R. Bose, J. Chou, V.S. Koshkin, A. Desai, S. Feng, A. …
• 1404P A phase II study of ZEN-3694 (ZEN), enzalutamide (ENZ), and pembrolizumab (P) in metastatic castration resistant prostate cancer (mCRPC): Interim safety results.
  Annals of Oncology 2022 T. Jindal, H. Han, P.S. Deshmukh, I. De Kouchkovsky, D. Kwon, H.T. Borno, V.S. Koshkin, A. Desai, R. Bose, J. Chou, T. Friedlander, E.J. Small, A. Angelidakis, M.S. Johnson, S. Feng, A. Patnaik, L. …
• 1751P Impact of squamous histology on clinical outcomes and molecular profiling in metastatic urothelial carcinoma (mUC) patients (pts) treated with newer therapies.
  Annals of Oncology 2022 P.S. Deshmukh, I. De Kouchkovsky, L. Zhang, T. Jindal, K. Reyes, E. Hernandez Romero, E. Chan, A. Desai, H.T. Borno, D. Kwon, A. Wong, R. Bose, R. Aggarwal, S. Porten, L. Fong, E.J. Small, J. Chou, T.…
• Ethnic and Racial Inequities in Cancer Screening During the COVID-19 Pandemic: a multi-site observational study in the United States.
  International Journal of Cancer Care and Delivery 2022 Dame Idossa, Hala T. Borno, Katarina Wang, Mark Pletcher, Gillian Gresham, Alison J. Canchola, Douglas S. Bell, Michael Matheny, Lisa Schilling, Amy M. Perkins, Kai Zheng, Lucila Ohno-Machado, Jihoon …
• Understanding the Current Therapeutic Landscape for Advanced Prostate Cancer.
  International Journal of Cancer Care and Delivery 2022 Noah S. Younger, Hala T. Borno
• Case Report: Clinical Characteristics and Outcomes of HIV Positive Patients With Metastatic Prostate Cancer Treated With Immunotherapy: A Case Series and Literature Review.
  Frontiers in oncology 2022 Idossa D, Friedlander T, Paller CJ, Ryan CJ, Borno HT
• Skeletal-related events after abiraterone or enzalutamide in patients with metastatic castration-resistant prostate cancer: A population-based study using the SEER-Medicare linked dataset.
  Urologic oncology 2022 Kwon DH, Paciorek A, Zhang L, Borno HT, Bucknor M, Small EJ, Aggarwal RR
• Evaluating predictors of food insecurity among patients with cancer in the safety-net setting.
  Journal of Clinical Oncology 2022 Ana I. Velazquez Manana, Hala Borno, Evelin Trejo, Sylvia Zhang, Abigail A. Rodriguez Saldana, Ivan C. Leung, Hilary K. Seligman, Tracy Kuo Lin
• Measuring the long commute: Experiences of a multi-ethnic cohort of patients enrolled in a financial reimbursement program for cancer clinical trials.
  Journal of Clinical Oncology 2022 Sheyla P Medina, Sylvia Zhang, Elena Nieves, Dana Dornsife, Robert G. Johnson, Darcy V. Spicer, Hala Borno
• Racial concordance and trust in health communications: A randomized trial of videos about prostate cancer.
  Journal of Clinical Oncology 2022 Stacy Loeb, Joseph Ravenell, Scarlett Lin Gomez, Hala Borno, Katherine Siu, Tatiana Sanchez Nolasco, Nataliya Byrne, Godfrey Wilson, Derek Griffith, Rob Crocker, Robert Sherman, Aisha Langford
• COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry.
  The oncologist 2022 Borno HT, Kim MO, Hong JC, Yousefi S, Lin A, Tolstykh I, Zhang S, McKay RR, Harismendy O, Cinar P, Rugo H, Koshkin VS, Rabow M, Wang C, Bailey A, Small EJ
• MP09-16 QUALITY OF INFORMATION IN SPANISH ON BRCA AND GENETIC TESTING IN PROSTATE CANCER ON YOUTUBE.
  Investigative Urology 2022 Brett Friedman, Kevin Pineault, Tatiana Sanchez Nolasco, Hala Borno, Veda Giri, Stacy Loeb
• Mobile Clinical Trial Matching Technology in Medical Oncology Clinic: A Pilot Feasibility Study.
  JCO clinical cancer informatics 2022 Borno HT, Zhang L, Zhang S, Kaplan C, Palmer NR, Bell A, Bakke B, Lin A, Aggarwal R, Small EJ
• The Problem of Hispanic/Latinx Under-Representation in Cancer Clinical Trials.
  JCO oncology practice 2022 Espinoza-Gutarra MR, Duma N, Aristizabal P, Segarra-Vazquez B, Borno H, Halbert CH, Simon MA, Velazquez AI
• Implementation of a Multisite Financial Reimbursement Program in Cancer Clinical Trials Integrated With Patient Navigation: A Pilot Randomized Clinical Trial.
  JCO oncology practice 2022 Borno HT, Zhang L, Zhang S, Lin TK, Skafel A, Nieves E, Dornsife D, Johnson R, Rhoads K, Small E, Spicer D
• Biomarkers predictive of response to enfortumab vedotin (EV) treatment in advanced urothelial cancer (aUC).
  Journal of Clinical Oncology 2022 Tanya Jindal, Li Zhang, Jonathan Chou, David Shui, Sima P. Porten, Anthony C. Wong, Emily Chan, Bradley A. Stohr, Ivan de Kouchkovsky, Hala Borno, Rohit Bose, Daniel H Kwon, Arpita Desai, Franklin W. …
• Evaluating therapeutic bladder cancer trial disparities in race/ethnicity.
  Journal of Clinical Oncology 2022 Ishaan Iyer, Sylvia Zhang, Hala Borno
• Serial stereotactic body radiation therapy for oligometastatic prostate cancer (PCa) detected by positron emission tomography (PET) imaging.
  Journal of Clinical Oncology 2022 David Shui, Hala Borno, Rohit Bose, Jonathan Chou, Arpita Desai, Lawrence Fong, Terence W. Friedlander, Franklin W. Huang, Vadim S Koshkin, Ivan de Kouchkovsky, Julian C. Hong, Osama Mohamad, Felix Y …
• Representation in Online Prostate Cancer Content Lacks Racial and Ethnic Diversity: Implications for Black and Latinx Men.
  The Journal of urology 2022 Loeb S, Borno HT, Gomez S, Ravenell J, Myrie A, Sanchez Nolasco T, Byrne N, Cole R, Black K, Stair S, Macaluso JN, Walter D, Siu K, Samuels C, Kazemi A, Crocker R, Sherman R, Wilson G, Griffith DM, …
• Evaluating the impact of financial toxicity among cancer clinical trial participants.
  International Journal of Cancer Care and Delivery 2022 Hala T. Borno, Sylvia Zhang, Tracy Kuo Lin, Li Zhang, Nynikka R. Palmer, Christopher Nguyen, Celia Kaplan, Charles J. Ryan
• What do you know? The role of race/ethnicity in clinical trial knowledge among patients with a gynecologic malignancy.
  Gynecologic Oncology 2022 Rosa Guerra, Celia Kaplan, Hala Borno, Edwin Alvarez, Jocelyn Chapman, Megan Swanson, Stefanie Ueda, Lee-may Chen
• Mobile Audio Recording Technology to Promote Informed Decision Making in Advanced Prostate Cancer.
  JCO oncology practice 2021 Kwon DH, Karthikeyan S, Chang A, Borno HT, Koshkin VS, Desai A, Bose R, Friedlander T, Rodvelt T, Li P, Small EJ, Aggarwal RR, Belkora J
• Being Present 2.0: Online Mindfulness-Based Program for Metastatic Gastrointestinal Cancer Patients and Caregivers.
  Global advances in health and medicine 2021 Dragomanovich HM, Dhruva A, Ekman E, Schoenbeck KL, Kubo A, Van Blarigan EL, Borno HT, Esquivel M, Chee B, Campanella M, Philip EJ, Rettger JP, Rosenthal B, Van Loon K, Venook AP, Boscardin C, Moran P…
• Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?
  NPJ breast cancer 2021 Abel MK, Melisko ME, Rugo HS, Chien AJ, Diaz I, Levine JK, Griffin A, McGuire J, Esserman LJ, Borno HT, Mukhtar RA
• The Distance Between Us: the COVID-19 Pandemic's Effects on Burnout Among Resident Physicians.
  Medical science educator 2021 Natsuhara KH, Borno HT
• Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High-intensity Aerobic and resistance exercise for Metastatic castrate-resistant Prostate cancer.
  Cancer medicine 2021 Kenfield SA, Van Blarigan EL, Panchal N, Bang A, Zhang L, Graff RE, Chen YH, Ryan CJ, Luke A, Newton RU, Tenggara I, Schultz B, Wang E, Lavaki E, Zuniga K, Pinto N, Borno H, Aggarwal R, Friedlander T,…
• Evaluating changes in “good safety monitoring” for cancer clinical trial participants during the COVID-19 pandemic.
  Journal of Clinical Oncology 2021 Meera Vimala Ragavan, Alyssa LaLanne, Andrea Skafel, Julian C. Hong, Anobel Y. Odisho, Sasha Yousefi, Eric Jay Small, Hala Borno
• Predictors of high financial distress in a national, multiethnic sample of patients with cancer.
  Journal of Clinical Oncology 2021 Meera Vimala Ragavan, Rosie Cunningham, Andrea Incudine, Hala Borno, Thomas Stivers
• 1571P COVID-19 positivity rates in patients with an active cancer diagnosis in the University of California Cancer Consortium.
  Annals of Oncology 2021 J. Hong, H.T. Borno, O. Harismendy, S. Yousefi, P. Cinar, H.S. Rugo, M-O. Kim, V.S. Koshkin, A. Bailey, R.R. McKay, E.J. Small
• Broad inclusion leads to maximal value – examining travel costs associated with clinical trial participation.
  2021 Hala T. Borno, Sylvia Zhang, Elena Nieves, Dana Dornsife, Robert Johnson, Darcy Spicer, Tracy K. Lin
• Implementation of a medical oncology fellow-initiated financial toxicity screening program in outpatient medical oncology clinics.
  2021 Hala T. Borno, Nichole Legaspi, Sam Brondfield, Errol Philip, Pelin Cinar, Li Zhang
• Prostate cancer patients' self-reported participation in research: an examination of racial/ethnic disparities.
  Cancer causes & control : CCC 2021 Palmer NR, Borno HT, Gregorich SE, Livaudais-Toman J, Kaplan CP
• Decreased enrollment of patients with advanced lobular breast cancer compared to ductal breast cancer in interventional clinical trials.
  Journal of Clinical Oncology 2021 Mary Kathryn Abel, Michelle E. Melisko, Hope S. Rugo, Amy Jo Chien, Italia Diaz, Julia K. Levine, Ann Griffin, Joseph McGuire, Laura Esserman, Hala Borno, Rita A. Mukhtar
• Immunogenic priming with 177 Lu-PSMA-617 plus pembrolizumab in metastatic castration resistant prostate cancer (mCRPC): A phase 1b study.
  Journal of Clinical Oncology 2021 Rahul Raj Aggarwal, Srey Luch Sam, Vadim S Koshkin, Eric Jay Small, Felix Y Feng, Ivan de Kouchkovsky, Daniel H Kwon, Terence W. Friedlander, Hala Borno, Rohit Bose, Jonathan Chou, Arpita Desai, Tammy…
• Patterns in cancer management changes for patients with COVID-19 in northern California.
  Journal of Clinical Oncology 2021 Michael Glover, Julie Wu, Daniel H Kwon, Sylvia Zhang, Solomon Henry, Douglas Wood, Daniel Rubin, Hala Borno, Eric Jay Small, Lidia Schapira, Vadim S Koshkin, Sumit Shah
• Rate of skeletal-related events (SREs) for abiraterone acetate (AA) versus enzalutamide (ENZ) in prostate cancer: A population-based study using the SEER-Medicare database.
  Journal of Clinical Oncology 2021 Daniel H Kwon, Alan Paciorek, Li Zhang, Hala Borno, Arpita Desai, Rohit Bose, Jonathan Chou, Lawrence Fong, Terence W. Friedlander, Franklin W. Huang, Vadim S Koshkin, Eric Jay Small, Rahul Raj …
• Updated results of phase II trial using escalating doses of neoadjuvant atezolizumab for cisplatin-ineligible patients with nonmetastatic urothelial cancer (NCT02451423).
  Journal of Clinical Oncology 2021 Divya V Natesan, Li Zhang, David Yoonsuk Oh, Sima P. Porten, Maxwell Meng, Raj Pruthi, Matthew R. Cooperberg, Peter Carroll, Jonathan Chou, Hala Borno, Rohit Bose, Arpita Desai, Daniel H Kwon, Anthony…
• Assessing Clinician Attitudes and Beliefs Around Financial Toxicity Screening in Medical Oncology Clinic.
  2021 Sylvia T Zhang, Errol J Philip, Nichole Legaspi, Lucky Ding, Tracy Kuo Lin, Hala T Borno
• Loneliness and symptom burden in oncology patients during the COVID-19 pandemic.
  Cancer 2021 Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno HT, Chang SM, Chen LM, Cohen B, Cooper BA, Hammer MJ, Kenfield SA, Kober KM, Laffan A, Levine JD, Pozzar R, Rhoads K, Tsai KK, Van Blarigan EL, Van …
• Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study.
  Journal of Onco-Nephrology 2021 Kelsey H Natsuhara, Li Zhang, Christopher A Carlos, Hala T Borno
• Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer.
  Cancer 2021 Kwon DH, Chou J, Yip SM, Reimers MA, Zhang L, Wright F, Dhawan MS, Borno HT, Desai A, Aggarwal RR, Wyatt AW, Small EJ, Alva AS, Chi KN, Feng FY, Koshkin VS
• Examining reporting and representation of patients with cancer in COVID-19 clinical trials.
  Cancer reports (Hoboken, N.J.) 2021 Rabow M, Wang C, Zhang S, Tahir PM, Small EJ, Borno HT
• Androgen deprivation therapy and risk of SARS-CoV-2 infection in men with prostate cancer: A University of California (UC) Health System registry study.
  Journal of Clinical Oncology 2021 Daniel Kwon, Rohit Vashisht, Hala Borno, Rahul Raj Aggarwal, Eric Jay Small, Atul Butte, Franklin W. Huang
• Assessing the impact of the COVID-19 pandemic on patients with genitourinary malignancies.
  Journal of Clinical Oncology 2021 Hala Borno, Sylvia Zhang, Scarlett Lin Gomez, Celia Kaplan, Christine Miaskowski, Julian Hong, Dame Idossa, Adina Bailey, Eric Jay Small
• INNOVATE (NRG-GU008): A randomized phase III trial of salvage radiotherapy and androgen deprivation therapy (ADT) with/without abiraterone and apalutamide for patients with node-positive prostate cancer after radical prostatectomy.
  Journal of Clinical Oncology 2021 Ronald C. Chen, Theodore Karrison, Colleen Anne Lawton, William Adrian Hall, Hala Borno, Mihaela Rosu, Ashesh B. Jani, David M. Schuster, Michael J. Seider, Jason A. Efstathiou, Edwin Melencio Posadas…
• Implementation of clinician-facing prostate cancer therapeutic clinical trial decision tool at a comprehensive cancer center.
  Journal of Clinical Oncology 2021 Hala Borno, Patricia Li, Sylvia Zhang, Dame Idossa, Arpita Desai, Tammy J. Rodvelt, Rohit Bose, Vadim S Koshkin, Jonathon Chou, Terence W. Friedlander, Franklin W. Huang, Eric Jay Small, Rahul Raj …
• Streamlining the genetics pipeline to increase testing for patients at risk for hereditary prostate cancer.
  Journal of Clinical Oncology 2021 Barry Tong, Hala Borno, Fern Alagala, Kelly Gordon, Eric Jay Small, Amy M. Lin, Amie Blanco, Mallika Sachdev Dhawan
• Cost-Effectiveness of Immunotherapy Treatments for Renal Cell Carcinoma: A Systematic Review.
  Kidney Cancer 2021 Errol J. Philip, Sylvia Zhang, Peggy Tahir, Daniel Kim, Francis Wright, Alexander Bell, Hala T. Borno
• Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry.
  Annals of oncology : official journal of the European Society for Medical Oncology 2021 Kwon DH, Vashisht R, Borno HT, Aggarwal RR, Small EJ, Butte AJ, Huang FW
• Integrating Financial Toxicity Assessment in Cancer Treatment: Implications for Medical Oncology Training.
  Journal of Health Science Research 2021 Errol J. Philip, Nichole Legaspi, Hala T. Borno
• Leveraging Social Media as a Thermometer to Gauge Patient and Caregiver Concerns: COVID-19 and Prostate Cancer.
  European urology open science 2021 Loeb S, Mihalcea R, Perez-Rosas V, Xu A, Taylor J, Byrne N, Walter D, Ness M, Robbins R, Zhang S, Killeen T, Natesan D, Borno HT
• Policy and Health: Leveraging a Social Determinants of Health Framework to Alleviate the Impact of the COVID-19 Pandemic on Patients With Cancer.
  JCO oncology practice 2020 Borno HT, Idossa D, Gomez SL
• Abstract PO-276: Lazarex Cancer Foundation (LCF) financial reimbursement programs (FRP) promote equitable access and inclusion among racial/ethnic minorities in therapeutic cancer clinical trials (TCT).
  Cancer Epidemiology Biomarkers & Prevention 2020 Dana L. Dornsife, Hala Borno, Darcy Spicer, Robert G. Johnson
• Evaluating determinants of receipt of molecular imaging in biochemical recurrent prostate cancer.
  Cancer medicine 2020 Borno HT, Kuo Lin T, Odisho AY, Desai A, Koshkin V, Werner K, Legaspi N, Bucknor M, Bell A, Zhang S, Hope TA
• Disparities in precision medicine-Examining germline genetic counseling and testing patterns among men with prostate cancer.
  Urologic oncology 2020 Borno HT, Odisho AY, Gunn CM, Pankowska M, Rider JR
• Utilization of a multisite financial reimbursement program to promote racial/ethnic diversity and inclusion in therapeutic cancer clinical trials: The iMPACT Study.
  Journal of Clinical Oncology 2020 Hala Borno, Sylvia Zhang, Elena Nieves, Dana Dornsife, Robert G. Johnson, Darcy V. Spicer
• Integration of electronic pathology reporting with clinical trial matching for advanced prostate cancer.
  2020 Hala Borno
• Integrating Financial Toxicity Assessment in Cancer Treatment: Implications for Medical Oncology Training.
  Journal of Health Science Research 2020 Errol J. Philip, Nichole Legaspi, Hala T. Borno
• Disparities in PET Imaging for Prostate Cancer at a Tertiary Academic Medical Center.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Bucknor MD, Lichtensztajn DY, Lin TK, Borno HT, Gomez SL, Hope TA
• Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic.
  Journal of pain and symptom management 2020 Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, Chen LM, Cohen B, Hammer MJ, Kenfield SA, Kober KM, Levine JD, Pozzar R, Rhoads KF, Van Blarigan EL, Van Loon K
• Oncology patients' perceptions of and experiences with COVID-19.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2020 Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, Chen LM, Cohen B, Cooper BA, Hammer MJ, Kenfield SA, Laffan A, Levine JD, Pozzar R, Tsai KK, Van Blarigan EL, Van Loon K
• Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry.
  Urologic oncology 2020 Borno HT, Cowan JE, Zhao S, Broering JM, Carroll PR, Ryan CJ
• COVID-19 disparities: An urgent call for race reporting and representation in clinical research.
  Contemporary clinical trials communications 2020 Borno HT, Zhang S, Gomez S
• Abstract A081: Trial Library: A pilot study to examine feasibility, acceptability, and preliminary estimates of efficacy for an online clinical trial matching website on patient-prompted conversations for prostate cancer clinical trials.
  Cancer Epidemiology Biomarkers & Prevention 2020 Hala T. Borno, Brian Bakke, Anke Hebig Prophet, Yoon-Ji Kim, Jan Yaeger, Jessica Chao, Pelin Cinar, Celia Kaplan, Eric Small, Christy Boscardin, Ralph Gonzales
• Abstract C053: Testicular cancer in Hispanics: Incidence of subtypes over time according to neighborhood sociodemographic factors in California.
  Cancer Epidemiology Biomarkers & Prevention 2020 Mindy C DeRouen, Meg McKinley, Sumit A Shah, Hala T Borno, Rhonda Aoki, Daphne Y Lichtensztajn, John T Leppert, James D Brooks, Benjamin Chung, Scarlett L Gomez, Iona Cheng
• Abstract D067: The REACT study: A feasibility study to develop and test the integration of a California Cancer Registry Early Case Ascertainment process via electronic pathology reporting with an online clinical trial matching tool.
  Cancer Epidemiology Biomarkers & Prevention 2020 Hala T Borno, Christine Duffy, Sylvia Zhang, Todd Golden, Zinnia Loya, Debby Oh, Anobel Odisho, Scarlett Lin Gomez
• Testicular cancer in Hispanics: incidence of subtypes over time according to neighborhood sociodemographic factors in California.
  Cancer causes & control : CCC 2020 DeRouen MC, McKinley M, Shah SA, Borno HT, Aoki R, Lichtensztajn DY, Leppert JT, Brooks JD, Chung BI, Gomez SL, Cheng I
• Sipuleucel-T (sip-T) and oral androgen axis inhibitors in black men being treated for metastatic castration-resistance prostate cancer (mCRPC): Observations from the Medicare Fee for Service (FFS) population.
  Journal of Clinical Oncology 2020 Hala Borno, Kelvin A. Moses, Paul Monk, Kate Fitch, Matthew Harmon, Scott Flanders, Rana R. McKay
• Streamlining the genetics pipeline to increase testing for patients at risk for hereditary prostate cancer.
  Journal of Clinical Oncology 2020 Barry Tong, Hala Borno, Eric Jay Small, Fern Alagala, Amie Blanco, Mallika Sachdev Dhawan
• Racial disparities and online health information: YouTube and prostate cancer clinical trials.
  BJU international 2020 Borno HT, Zhang S, Bakke B, Bell A, Zuniga KB, Li P, Chao K, Sabol A, Killeen T, Hong H, Walter D, Loeb S
• Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research?
  Contemporary clinical trials 2020 Borno HT, Small EJ
• The limitations of today's clinical guidance: Atypical femoral fracture and long-term bone-modifying agents in the oncology setting.
  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2020 Cheung E, Borno HT
• Disparities in receipt of molecular imaging in biochemical recurrent prostate cancer.
  Journal of Clinical Oncology 2020 Hala Borno, Tracy Kuo Lin, Anobel Y. Odisho, Arpita Desai, Vadim S Koshkin, Kalin Werner, Nichole Legaspi, Alexander Bell, Thomas Hope
• Efficacy of immune checkpoint inhibitors (ICIs) in rare histological variants of bladder cancer.
  Journal of Clinical Oncology 2020 Errol James Philip, Francis Wright, Daniel Myung Kim, Daniel Kwon, Hansen Ho, Son Ho, Edna Cheung, Emily Chan, Sima P. Porten, Anthony C. Wong, Hala Borno, Arpita Desai, Jonathan Chou, David Yoonsuk …
• REACT: A feasibility study to test the integration of a cancer registry early case ascertainment process via electronic pathology reporting with an online clinical trial matching tool.
  Journal of Clinical Oncology 2020 Hala Borno, Christine Duffy, Sylvia Zhang, Zinnia Loya, Todd Golden, Debora Oh, Anobel Y. Odisho, Scarlett Lin Gomez
• The Problem of Underrepresentation: Black Participants in Lifestyle Trials Among Patients with Prostate Cancer.
  Journal of racial and ethnic health disparities 2020 Zuniga KB, Borno H, Chan JM, Van Blarigan EL, Friedlander TW, Wang S, Zhang L, Kenfield SA
• Treatment outcomes in metastatic prostate cancer patients with DNA damage repair mutations.
  Journal of Clinical Oncology 2020 Daniel Kwon, Francis Wright, Li Zhang, Jonathan Chou, Hala Borno, Arpita Desai, David Yoonsuk Oh, YaoYao Guan Pollock, Rohit Bose, Franklin W. Huang, Thomas Hope, Terence W. Friedlander, Lawrence Fong…
• Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group.
  Urologic oncology 2019 Narayan V, Harrison M, Cheng H, Kenfield S, Aggarwal R, Kwon D, McKay R, Hauger R, Hart N, Conzen S, Borno H, Jim H, Dicker A, Dorff T, Moslehi J, Mucci L, Parsons JK, Saad F, Soule H, Morgans A, Ryan…
• A step towards equitable clinical trial recruitment: a protocol for the development and preliminary testing of an online prostate cancer health information and clinical trial matching tool.
  Pilot and feasibility studies 2019 Borno HT, Bakke BM, Kaplan C, Hebig-Prophet A, Chao J, Kim YJ, Yeager J, Cinar P, Small E, Boscardin C, Gonzales R
• How current reporting practices may mask differences: A call for examining cancer-specific demographic enrollment patterns in cancer treatment clinical trials.
  Contemporary clinical trials communications 2019 Borno HT, Small EJ, Zhang L, DeRouen MC, Griffin A, McGuire J, Ryan CJ, Hiatt RA, Kaplan CP
• Ethnic disparities among men with prostate cancer undergoing germline testing.
  Urologic oncology 2019 Kwon DH, Borno HT, Cheng HH, Zhou AY, Small EJ
• An electronic registry to improve adherence to active surveillance monitoring among men with prostate cancer at a safety-net hospital: protocol for a pilot study.
  Pilot and feasibility studies 2019 Cedars B, Lisker S, Borno HT, Kamal P, Breyer B, Sarkar U
• Tailoring survivorship to diverse populations with genitourinary malignancies.
  Urologic oncology 2019 Borno HT, Dixit N
• Food insecurity screening: A missing piece in cancer management.
  Cancer 2019 Patel KG, Borno HT, Seligman HK
• Germline Genetic Testing in Advanced Prostate Cancer - Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium
  Clinical Genitourinary Cancer 2019 Channing J. Paller, Emmanuel S. Antonarakis, Tomasz M. Beer, Hala T. Borno, Maria I. Carlo, Daniel J. George, Julie N. Graff, Shilpa Gupta, Elisabeth I. Heath, Celestia S. Higano, Rana R. McKay, …
• Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
  Clinical genitourinary cancer 2019 Paller CJ, Antonarakis ES, Beer TM, Borno HT, Carlo MI, George DJ, Graff JN, Gupta S, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Petrylak DP, Rettig MB, Ryan CJ, Taplin ME, Whang YE, Vinson…
• An electronic registry to improve adherence to active surveillance monitoring among men with prostate cancer at a safety-net hospital: protocol for a pilot study
  Pilot and Feasibility Studies 2019 Benjamin Cedars, Sarah Lisker, Hala T. Borno, Puneet Kamal, Benjamin Breyer, and Urmimala Sarkar
• Differential use of medical versus surgical androgen deprivation therapy for patients with metastatic prostate cancer.
  Cancer 2018 Borno HT, Lichtensztajn DY, Gomez SL, Palmer NR, Ryan CJ
• Apalutamide and its use in the treatment of prostate cancer.
  Future oncology (London, England) 2018 Borno HT, Small EJ
• Journal of Clinical Oncology
  Implementation of a fellow-initiated financial toxicity screening tool in medical oncology clinics. 2018 Samuel Craig Brondfield, Hala T. Borno, Claire Mulvey, Li-Wen Huang, Pelin Cinar.
• A bilingual, Internet-based, targeted advertising campaign for prostate cancer clinical trials: Assessing the feasibility, acceptability, and efficacy of a novel recruitment strategy.
  Contemporary clinical trials communications 2018 Kaplan CP, Siegel A, Leykin Y, Palmer NR, Borno H, Bielenberg J, Livaudais-Toman J, Ryan C, Small EJ
• Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers.
  PloS one 2018 Atreya CE, Kubo A, Borno HT, Rosenthal B, Campanella M, Rettger JP, Joseph G, Allen IE, Venook AP, Altschuler A, Dhruva A
• At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials.
  The oncologist 2018 Borno HT, Zhang L, Siegel A, Chang E, Ryan CJ
• Journal of Clinical Oncology
  Minority Equity and Recruitment Into Trials program: Self-assessment of disease-specific cancer clinical trial recruitment patterns at a comprehensive cancer center. 2018 Hala T Borno, Joseph P. McGuire, Ann C. Griffin, Charles J. Ryan, Celia Kaplan, Eric Jay Small
• CaPSURE update: Examining primary treatment and survival among men with prostate cancer and bony metastatic disease.
  Journal of Clinical Oncology 2018 Hala Borno, Janet E. Cowan, Shoujun Zhao, Peter Carroll, Charles J. Ryan
• Minority Equity and Recruitment Into Trials program: Self-assessment of disease-specific cancer clinical trial recruitment patterns at a comprehensive cancer center.
  Journal of Clinical Oncology 2018 Hala Borno, Joseph P. McGuire, Ann C. Griffin, Charles J. Ryan, Celia Kaplan, Eric Jay Small
• Blood and conflict: managing bleeding disorders in Gaza.
  Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 2018 Borno H
• An unusual manifestation of diabetic ketoacidosis and acute colonic pseudo-obstruction.
  JRSM open 2017 Natalini J, Borno H, Jin L, Jensen T
• Improving documentation of surrogate decision makers in medical oncology clinic.
  Journal of Clinical Oncology 2017 Melisa L. Wong, Hala Borno, Reena Mahajan, Kara E. Bischoff, Brook Calton, Emily K. Bergsland, Won Kim, Rahul Raj Aggarwal, Katy K. Tsai, Pelin Cinar
• The problem of representativeness of clinical trial participants: understanding the role of hidden costs.
  Journal of health services research & policy 2016 Borno H, Siegel A, Ryan C
• Incidence of cleft lip and palate in the palestinian territories: a retrospective study from the Makassed Hospital neonatal unit.
  The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 2013 Borno HT, Hussein EA, Dudin A, van Aalst JA
• Cleft Lip and Palate Diagnosis and Management
  Birthing and Building Nascent Cleft Teams in Developing Countries 2012 Hussein E, Borno HT, van Aalst JA